Collaboration builds clinical foundation for GNX1021, a first-in-class glycan-directed ADC being developed for gastric cancer patients NEW TAIPEI CITY, Taiwan, Nov. 24, 2025 /PRNewswire/ -- GlycoNex, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback